(October 5, 2016) A new analysis published in the American Journal of Obstetrics and Gynecology determined the impact of gynecologic surgeon volumes on patient outcomes. Reviewing fourteen studies that involved over 700,000 women, the researchers found that low-volume surgeons (categorized as those performing the procedure approximately once a month or less) were found to have … Continued
(October 5, 2016) A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an accompanying molecule, and t-cells, which are a body’s natural defense against tumor growth. PD-L1 can be found on both cancer cells and healthy cells but, … Continued
We are so excited to announce that Kiehl’s will be donating $25,000 to OCRFA during September. We are thankful for their continued support of the ovarian cancer community and commitment to change the future of ovarian cancer! #30DaysofTeal Visit Kiehl’s LifeRide for OCRFA in Los Angeles! for event details.
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible.
Let’s take a minute today to thank our doctors, our nurses, and all of our medical professionals who help us and our loved ones with ovarian cancer. The ovarian community salutes these amazing people working on the front lines every day. #30DaysofTeal Today’s post is sponsored by Immunogen
Are you ready to look for a clinical trial? OCRFA offers two great resources: Carebox and Cure Forward. Carebox provides a comprehensive yet simplified system for women to find and link to clinical trial options for ovarian cancer. Cure Forward provides access to clinical trials and targeted treatment options, and can help you understand precision … Continued
“The Sole of Ovarian Cancer Awareness” is SKICKS tennis style low top unisex sneaker in teal. SKICKS will donate 15% of every sale of SKICKS TEALS to OCRFA. Just enter promo code “OCRFA” when you check out.#30DaysofTeal Visit http://skicks.com/products/ovarian-cancer-awareness-teals
Did you know that sending your local paper a Letter to the Editor is a great way to get your community involved in National Ovarian Cancer Awareness Month? Click this link for a template to get started. #30DaysofTeal
We know there are many myths and fears about clinical trial participation out there and we want to break them! Clinical trials help pave the way for better treatments and diagnostic tests for ovarian cancer. Get the facts and learn if a clinical trial might be a good option for you: www.ovariancancer.org/clinicaltrials #30DaysofTeal
NEW YORK, Sept. 12, 2016 /PRNewswire/ — Wheels Up Founder and CEO Kenny Dichter today announced the launch of WHEELS UP CARES, a philanthropic initiative to raise awareness and funds for a cause important to the Company, and its members. Through the WHEELS UP CARES program, a Wheels Up Beechcraft King Air 350i aircraft is custom-designed to represent … Continued
One in 75 women will be diagnosed with ovarian cancer during her lifetime. Spread awareness today by sharing these graphics. See our full ovarian cancer infographic. #30DaysofTeal
On September 13th, Abcodia Incorporated, the makers of the ROCA Test, released this statement*, following the safety guidance put out by the FDA last week. ROCA Test sales are now suspended in the United States. *Note: The original publication of this article linked to an article that has since been archived. For more updated information, please visit … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
